研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

肿瘤坏死因子刺激的基因 6 通过抑制 NLRC4 炎性体介导的星形胶质细胞焦亡来改善蛛网膜下腔出血后的早期脑损伤。

Tumor necrosis factor-stimulated gene-6 ameliorates early brain injury after subarachnoid hemorrhage by suppressing NLRC4 inflammasome-mediated astrocyte pyroptosis.

发表日期:2024 May
作者: Mingxiang Ding, Lei Jin, Boyang Wei, Wenping Cheng, Wenchao Liu, Xifeng Li, Chuanzhi Duan
来源: Neural Regeneration Research

摘要:

蛛网膜下腔出血的发病率和死亡率较高,且缺乏有效的治疗方法。细胞焦亡是蛛网膜下腔出血后早期脑损伤的重要机制。此前的研究已证实肿瘤坏死因子刺激基因6(TSG-6)可以通过抑制氧化应激和细胞凋亡发挥神经保护作用。然而,迄今为止还没有研究探讨TSG-6是否可以减轻蛛网膜下腔出血后早期脑损伤的焦亡。本研究采用血管内穿孔法建立C57BL/6J小鼠蛛网膜下腔出血模型。我们的结果表明,TSG-6 表达主要在星形胶质细胞中检测到,此外还有 NLRC4 和gasdermin-D (GSDMD)。蛛网膜下腔出血后NLRC4、GSDMD及其N末端结构域(GSDMD-N)和cleaved caspase-1的表达显着增强,并伴有脑水肿和神经功能损害。为了探索TSG-6如何影响蛛网膜下腔出血后早期脑损伤期间的细胞焦亡,将重组人TSG-6或靶向TSG-6的siRNA注射到脑室中。外源性 TSG-6 给药下调 NLRC4 和细胞焦亡相关蛋白的表达,并减轻脑水肿和神经功能缺损。此外,TSG-6敲低进一步增加了NLRC4的表达,并伴有更严重的星形胶质细胞焦亡。总之,我们的研究表明,TSG-6 通过抑制 NLRC4 炎性体激活诱导的星形胶质细胞焦亡,为蛛网膜下腔出血后的早期脑损伤提供神经保护。
Subarachnoid hemorrhage is associated with high morbidity and mortality and lacks effective treatment. Pyroptosis is a crucial mechanism underlying early brain injury after subarachnoid hemorrhage. Previous studies have confirmed that tumor necrosis factor-stimulated gene-6 (TSG-6) can exert a neuroprotective effect by suppressing oxidative stress and apoptosis. However, no study to date has explored whether TSG-6 can alleviate pyroptosis in early brain injury after subarachnoid hemorrhage. In this study, a C57BL/6J mouse model of subarachnoid hemorrhage was established using the endovascular perforation method. Our results indicated that TSG-6 expression was predominantly detected in astrocytes, along with NLRC4 and gasdermin-D (GSDMD). The expression of NLRC4, GSDMD and its N-terminal domain (GSDMD-N), and cleaved caspase-1 was significantly enhanced after subarachnoid hemorrhage and accompanied by brain edema and neurological impairment. To explore how TSG-6 affects pyroptosis during early brain injury after subarachnoid hemorrhage, recombinant human TSG-6 or a siRNA targeting TSG-6 was injected into the cerebral ventricles. Exogenous TSG-6 administration downregulated the expression of NLRC4 and pyroptosis-associated proteins and alleviated brain edema and neurological deficits. Moreover, TSG-6 knockdown further increased the expression of NLRC4, which was accompanied by more severe astrocyte pyroptosis. In summary, our study revealed that TSG-6 provides neuroprotection against early brain injury after subarachnoid hemorrhage by suppressing NLRC4 inflammasome activation-induced astrocyte pyroptosis.